Arcellx Inc (ACLX)

54.72 +1.47 (+2.76%) USD  |  NASDAQ  |  Jul 03, 16:00
More

Arcellx Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Long Term Deferred Assets (Quarterly) Data

View and export this data back to 2020. Upgrade now.
Date Value
September 30, 2022 --
June 30, 2022 --
March 31, 2022 --
Date Value
December 31, 2021 --
September 30, 2021 --
December 31, 2020 --

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

--
Minimum
Mar 2022
Upgrade
Maximum
Dec 2021
Upgrade
Average
Upgrade
Median

Long Term Deferred Assets (Quarterly) Benchmarks

BridgeBio Pharma Inc --
Gilead Sciences Inc --
Agios Pharmaceuticals Inc --
Krystal Biotech Inc --
Arvinas Inc --